HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 364 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,435,000 | +4.6% | 78,071 | -5.2% | 1.95% | +46.8% |
| Q1 2022 | $3,285,000 | -6.0% | 82,384 | -5.2% | 1.33% | +7.9% |
| Q4 2021 | $3,496,000 | -2.0% | 86,939 | -0.8% | 1.23% | -3.1% |
| Q3 2021 | $3,566,000 | -8.0% | 87,654 | +2.6% | 1.27% | -6.9% |
| Q2 2021 | $3,878,000 | +6.7% | 85,409 | -2.1% | 1.37% | +3.1% |
| Q1 2021 | $3,635,000 | -4.3% | 87,201 | -2.0% | 1.33% | -9.2% |
| Q4 2020 | $3,799,000 | +66.4% | 88,941 | +2.4% | 1.46% | +39.7% |
| Q3 2020 | $2,283,000 | -0.8% | 86,856 | +1.2% | 1.05% | -10.5% |
| Q2 2020 | $2,301,000 | +45.4% | 85,818 | -2.5% | 1.17% | +20.4% |
| Q1 2020 | $1,583,000 | +1.7% | 87,991 | +0.3% | 0.97% | +35.4% |
| Q4 2019 | $1,556,000 | -50.8% | 87,766 | -57.0% | 0.72% | -51.6% |
| Q3 2019 | $3,165,000 | -10.2% | 204,089 | -0.5% | 1.48% | -10.0% |
| Q2 2019 | $3,523,000 | +7.1% | 205,084 | +0.4% | 1.64% | +0.5% |
| Q1 2019 | $3,290,000 | +10.1% | 204,349 | +0.0% | 1.64% | -5.1% |
| Q4 2018 | $2,989,000 | -25.7% | 204,277 | -7.7% | 1.72% | +0.9% |
| Q3 2018 | $4,022,000 | +8.1% | 221,380 | +0.4% | 1.71% | +3.4% |
| Q2 2018 | $3,719,000 | -14.0% | 220,475 | -0.1% | 1.65% | -20.5% |
| Q1 2018 | $4,323,000 | +32.0% | 220,670 | +36.5% | 2.08% | +49.4% |
| Q4 2017 | $3,276,000 | +17.5% | 161,675 | +0.8% | 1.39% | +11.9% |
| Q3 2017 | $2,787,000 | +35.0% | 160,460 | -0.4% | 1.24% | +33.0% |
| Q2 2017 | $2,065,000 | -2.6% | 161,090 | -1.6% | 0.94% | -2.6% |
| Q1 2017 | $2,121,000 | +22.7% | 163,640 | -6.5% | 0.96% | +20.0% |
| Q4 2016 | $1,729,000 | +11.7% | 174,975 | +36.6% | 0.80% | +15.3% |
| Q3 2016 | $1,548,000 | – | 128,110 | – | 0.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 14,092,771 | $256,066,000 | 16.64% |
| BB BIOTECH AG | 8,247,860 | $149,864,000 | 3.97% |
| MSD Partners, L.P. | 2,245,000 | $40,792,000 | 3.07% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 428,633 | $5,969,000 | 2.84% |
| First Light Asset Management, LLC | 885,523 | $16,090,000 | 2.60% |
| SNYDER CAPITAL MANAGEMENT L P | 2,387,350 | $43,378,000 | 1.93% |
| Sterling Global Strategies LLC | 22,000 | $400,000 | 1.74% |
| Taylor Wealth Management Partners | 221,380 | $4,022,000 | 1.71% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,228,399 | $167,680,000 | 1.68% |
| DOHENY ASSET MANAGEMENT /CA | 124,393 | $2,260,000 | 1.18% |